T��V Rheinland Moo cards eligible for 39 this capsule cancer rehabilitation preferred health network product honors _dsdsd

2010 is the acrylic, Zhejiang Pharmaceutical Co Ltd was awarded the harvest year, one of the company's flagship product, that is, with regulation of immunity and cancer adjuvant treatment of health food products--the role of "this" capsules of 2009, access to "the fifth World Health Assembly" after the specified product Award, for two consecutive years in the 2009--2010 years was named the first health portal 39 cancer rehabilitation preferred health network products, at the same time the company won the health food industry credit enterprise of Zhejiang Province, and many other honors. "this" first capsule is SFDA approval of ginsenoside Rh2 unilaterally, with industry benchmarks. Contents of ginsenosides in Panax ginseng Rh2 is very low, only one out of 10,000 in natural conditions, but also extremely difficult to extract. "This" capsule's exclusive patented technology greatly increased extraction rate of ginsenoside Rh2, similar to ginseng health food for raw materials for cancer patients, is the highest content of a product. listed since four years, "this" capsule sales are more prominent in the Yangtze River Delta region, on the effect of Panax ginseng East three provinces of the high degree of recognition on the recognition of this capsule is relatively high, other areas, such as Henan, Shaanxi Province, is a better sales, as far as Hong Kong, Macao, Taiwan and other places, such as Federal Express to send, within 24 hours of delivery in large cities are acrylic drug industry promised delivery speeds to consumers. Four years of "this" capsule has always been to maintain a good reputation in the industry, not received any complaint, bring tangible benefits for consumers. also, the "this" capsules in two consecutive years is one of the most well-known health Internet sites in China "39 health network" as cancer rehabilitation preferred products. "this" capsule manufacturers acrylic industries, Ltd affiliated to Zhejiang and Hainan Asia pharmaceutical group, its unique cold medicine class in China well-known trademark "crack cocaine" cold medicine has gone through more than 20 years of twists, and believe that as the first Asian pharmaceutical health products in Hainan Province "this capsule", also holds the company "supply good medicine, to serve the community" concept for the well-being of consumers to more. T��V Rheinland Moo cards eligible for 39 this capsule cancer rehabilitation preferred health network product honors from cancer-cancer health network, communication platform for cancer network-China's leading cancer tumors. Ginsenoside Rh2 with regard to the combination of medication and treatment of cancer, and their synergistic toxicity reduction function is very significant. Practice has shown that ginsenoside Rh2 with chemotherapy, synergy would serve as a drug, enhancing chemotherapy effects, reduce the side effects of chemotherapy drugs. And radiotherapy used together can counteract-Ray radiotherapy on peripheral blood cell damage, and enhance endurance in radiation therapy, radiotherapy full course to a successful conclusion. Ginsenoside Rh2 will also significantly enhance the body's immune function, can strengthen the patient's physical fitness and disease resistance, reducing the chances of infection, reduce the rate of cancer recurrence. In addition, studies have shown that ginsenoside Rh2 (effects of nurse) inhibits cancer cell growth in itself added value, through differentiation, direct inhibition of many cancer cells, and make it back to the evolution and transformation of normal cells, and finally complete cure of the disease the rehabilitation process. Oncologists inquiry hotline: 400-88-54321